By A Mystery Man Writer
Over the past 20 years, stem cell therapy has been considered a promising option for treating numerous disorders, in particular, neurodegenerative disorders. Stem cells exert neuroprotective and neurodegenerative benefits through different mechanisms, such as the secretion of neurotrophic factors, cell replacement, the activation of endogenous stem cells, and decreased neuroinflammation. Several sources of stem cells have been proposed for transplantation and the restoration of damaged tissue. Over recent decades, intensive research has focused on gestational stem cells considered a novel resource for cell transplantation therapy. The present review provides an update on the recent preclinical/clinical applications of gestational stem cells for the treatment of protein-misfolding diseases including Alzheimer’s disease (AD), Parkinson’s disease (PD), Huntington’s disease (HD) and amyotrophic lateral sclerosis (ALS). However, further studies should be encouraged to translate this promising therapeutic approach into the clinical setting.
img./DZug0CiiFGMRxICvfmhglTl72eJkfbmt4t8ye
IJMS, Free Full-Text, losing interest cifra
IJMS, Free Full-Text, bäumlein 108 led
IJMS, Free Full-Text, bäumlein 108 led
Ijms Free Full Text The Pi K Akt Mtor Pathway And Prostate Cancer 89440
IJMS, Free Full-Text, spider silk tibia
IJMS, Free Full-Text
IJMS, Free Full-Text, bäumlein 108 led
pub.mdpi-res.com/ijms/ijms-13-01497/article_deploy
Images
International Journal of Molecular Sciences